- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Poolbeg Pharma PLC (POLB)
Poolbeg Pharma PLC stock price live, this page displays LON POLB stock exchange data. View the POLB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Poolbeg Pharma PLC real time stock price chart below.
What Is the Poolbeg Pharma PLC Stock Price Today?
The Poolbeg Pharma PLC stock price today is 4.35.
What Is the Stock Symbol for Poolbeg Pharma PLC?
The stock symbol for Poolbeg Pharma PLC is "POLB."
What Stock Exchange Does Poolbeg Pharma PLC Trade On?
Poolbeg Pharma PLC is listed and trades on the London stock exchange.
Is Poolbeg Pharma PLC a Good Stock to Buy?
Determining whether Poolbeg Pharma PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the POLB quote. (ISIN: GB00BKPG7Z60)
What Is the Poolbeg Pharma PLC Stock Price Today?
The Poolbeg Pharma PLC stock price today is 4.35.
What Is the Stock Symbol for Poolbeg Pharma PLC?
The stock symbol for Poolbeg Pharma PLC is "POLB."
What Stock Exchange Does Poolbeg Pharma PLC Trade On?
Poolbeg Pharma PLC is listed and trades on the London stock exchange.
Is Poolbeg Pharma PLC a Good Stock to Buy?
Determining whether Poolbeg Pharma PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the POLB quote. (ISIN: GB00BKPG7Z60)
London
Currency in GBP
4.35
-0.20(-4.40%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.20
4.50
52 wk Range
2.40
5.20
POLB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.204.50
52 wk Range
2.405.20
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
POLB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
19.00
Upside
+336.78%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 19.00
(+336.78% Upside)
Earnings
Latest Release
Mar 31, 2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
Compare POLB to Peers and Sector
Metrics to compare | POLB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPOLBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.4x | −0.9x | −0.5x | |
PEG Ratio | −0.30 | 0.01 | 0.00 | |
Price/Book | 3.6x | 1.3x | 2.6x | |
Price / LTM Sales | - | 1.4x | 3.2x | |
Upside (Analyst Target) | 322.2% | 152.7% | 47.8% | |
Fair Value Upside | Unlock | 17.8% | 5.9% | Unlock |
Poolbeg Pharma PLC, a clinical-stage biopharmaceutical company, focused on acquiring, developing, and commercialising of medicines for unmet medical needs in the United Kingdom. The company develops POLB 001, which is completed phase 1 clinical study for cancer immunotherapy-induced cytokine release syndrome. It also developing oral encapsulated GLP-1R agonist for obesity and diabetes treatment; and AI program, a novel drug discovery therapies for the treatment of influenza and respiratory syncytial viruses. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Poolbeg Pharma (POLB) Stock Price Today?
The Poolbeg Pharma stock price today is 4.35 GBP.
What Stock Exchange Does Poolbeg Pharma Trade On?
Poolbeg Pharma is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Poolbeg Pharma?
The stock symbol for Poolbeg Pharma is "POLB."
What Is the Poolbeg Pharma Market Cap?
As of today, Poolbeg Pharma market cap is 30.67M GBP.
What Is Poolbeg Pharma's Earnings Per Share (TTM)?
The Poolbeg Pharma EPS (TTM) is -0.01.
When Is the Next Poolbeg Pharma Earnings Date?
Poolbeg Pharma will release its next earnings report on Mar 31, 2026.
From a Technical Analysis Perspective, Is POLB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Poolbeg Pharma Stock Split?
Poolbeg Pharma has split 0 times.
How Many Employees Does Poolbeg Pharma Have?
Poolbeg Pharma has 16 employees.
What is the current trading status of Poolbeg Pharma (POLB)?
As of May 09, 2026, Poolbeg Pharma (POLB) is trading at a price of 4.35 GBP, with a previous close of 4.55 GBP. The stock has fluctuated within a day range of 4.20 GBP to 4.50 GBP, while its 52-week range spans from 2.40 GBP to 5.20 GBP.
What Is Poolbeg Pharma (POLB) Price Target According to Analysts?
The average 12-month price target for Poolbeg Pharma is 19.00 GBP, with a high estimate of 19 GBP and a low estimate of 19 GBP. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +336.78% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.